SCHEMBL7960846

SCHEMBL7960846

O=C(O)CCc1cnc2n1CCCCC2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
HPGD P15428 2/20 0.43
HTT P42858 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.40
MAPK1 P28482 1/20 0.40
SLC27A1 Q6PCB7 1/20 0.37
POLB P06746 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
P4HTM Q9NXG6 1/20 0.36
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7448909 0.85 LMNA (0.46) LMNAHPGDHTTMEN1KMT2A
SCHEMBL28803885 0.83 HPGD (0.43) LMNAHPGDHTTMEN1KMT2A
SCHEMBL8233211 0.76 HPGD (0.42) LMNAHPGDHTTMEN1KMT2A
SCHEMBL5656897 0.76 HPGD (0.44) LMNAHPGDHTTMEN1KMT2A
SCHEMBL2266264 0.76 RXFP1 (0.41) LMNAHPGDHTTMEN1KMT2A
SCHEMBL10235437 0.74 MAPK1 (0.50) LMNAHPGDHTTMEN1KMT2A
SCHEMBL31032248 0.73 LMNA (0.49) LMNAHPGDHTTMEN1KMT2A
SCHEMBL7963436 0.73 F10 (0.51) HPGDHTTMEN1KMT2ANPC1
SCHEMBL10235027 0.73 MAPK1 (0.47) LMNAHPGDHTTMEN1KMT2A
SCHEMBL10185312 0.71 SLC27A1 (0.47) LMNAHPGDHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed